« Previous
Next »
European Journal of Vascular & Endovascular Surgery
Volume 34, Issue 4
, Pages 483-488
, October 2007
Hereditary Thrombophilia and Venous Thromboembolism: Critical Evaluation of the Clinical Implications of Screening
References
- . The natural history of venous thromboembolism: impact on ventilation/perfusion scan reporting. Semin Nucl Med. 2002 July;32(3):159–172
- A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991 May;151(5):933–938
- . Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998 March 23;158(6):585–593
- . The Leiden Thrombophilia Study (LETS). Thromb Haemost. 1997 August;78(1):631–635
- Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004 July 1;117(1):19–25
- . Inherited risk factors for venous thrombosis. Hematology Am Soc Hematol Educ Program. 2005;452–457
- . Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA. 2005 May 18;293(19):2352–2361
- . Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003 August 16;362(9383):523–526
- The PROCARE group. Is recurrent venous thromboembolism more frequent in homozygous patients for the factor V Leiden mutation than in heterozygous patients?. Blood Coagul Fibrinolysis. 2003 September;14(6):523–529
- Recurrence rate after a first venous thrombosis in patients with familial thrombophilia. Arterioscler Thromb Vasc Biol. 2005 September;25(9):1992–1997
- Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 September;126(Suppl. 3):338S–400S
- Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost. 2005 March;3(3):459–464
- . Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med. 1993 July 12;153(13):1557–1562
- Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 1996 August 17;348(9025):423–428
- . Pros and cons of thrombophilia testing: cons. J Thromb Haemost. 2003 March;1(3):412–413
- . An evaluation of thrombophilia screening in an urban tertiary care medical center: a “real world” experience. Am J Clin Pathol. 2006 July;126(1):120–127
PII: S1078-5884(07)00328-0
doi: 10.1016/j.ejvs.2007.04.023
© 2007 European Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
European Journal of Vascular & Endovascular Surgery
Volume 34, Issue 4
, Pages 483-488
, October 2007
